 | |
| Industry | Pharmaceuticals |
|---|---|
| Founded | 1998 |
| Defunct | 2012 |
| Fate | Acquired by Gilead Sciences in 2012 |
| Headquarters | , United States |
Key people | Raymond Schinazi Dennis Liotta |
Pharmasset Inc. was a pharmaceutical company based in Princeton, New Jersey in the United States. The company develops antiviral drugs for HIV (including racivir), hepatitis B (including clevudine, marketed as Levovir), and hepatitis C.[1] In November 2011, Pharmasset was acquired by Gilead for $11.2 billion.[2]
- ^ "Pharmasset Inc (VRUS:US)." Bloomberg.
- ^ Tom Murphy (November 21, 2011). "Gilead Sciences to buy Pharmasset for $11 billion". Bloomberg Businessweek. Archived from the original on September 25, 2013.